Palvella Therapeutics

0 followers


Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.

Industries

Headquarters

Stage

Employees

Links

Wes Kaupinen
President & CEO

Wes Kaupinen

Collapse
Braham Shroot
Chief Scientific Officer
Jeff Martini
SVP, R&D & Scientific Affairs
Pam Swiggard
VP, Regulatory Affairs
Emily Cook
SVP, Clinical Operations
Kathleen McGowan
VP, Finance & Operations
Jason Connor
VP, Clinical & Biostatistics
Colleen Pellegrini
Associate Director, Site and Trial Management
Alexis Lawthers
Clinical Trial Manager
Sam Vuong
Manager, CMC